Literature DB >> 8903231

HIV-1 group O virus identified for the first time in the United States.

M A Rayfield1, P Sullivan, C I Bandea, L Britvan, R A Otten, C P Pau, D Pieniazek, S Subbarao, P Simon, C A Schable, A C Wright, J Ward, G Schochetman.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8903231      PMCID： PMC2626795          DOI： 10.3201/eid0203.960307

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


× No keyword cloud information.
  7 in total

1.  Surveillance for human immunodeficiency virus type 1 group O infections in the United States.

Authors:  C P Pau; D J Hu; C Spruill; C Schable; E Lackritz; M Kai; J R George; M A Rayfield; T J Dondero; A E Williams; M P Busch; A E Brown; F E McCutchan; G Schochetman
Journal:  Transfusion       Date:  1996-05       Impact factor: 3.157

2.  Detection of diverse HIV-1 genetic subtypes in the USA.

Authors:  S K Brodine; J R Mascola; P J Weiss; S I Ito; K R Porter; A W Artenstein; F C Garland; F E McCutchan; D S Burke
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

3.  The ribosomal database project.

Authors:  N Larsen; G J Olsen; B L Maidak; M J McCaughey; R Overbeek; T J Macke; T L Marsh; C R Woese
Journal:  Nucleic Acids Res       Date:  1993-07-01       Impact factor: 16.971

4.  Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.

Authors:  C Schable; L Zekeng; C P Pau; D Hu; L Kaptue; L Gurtler; T Dondero; J M Tsague; G Schochetman; H Jaffe
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

5.  Epidemiologic and evolutionary relationships between Romanian and Brazilian HIV-subtype F strains.

Authors:  C I Bandea; A Ramos; D Pieniazek; R Pascu; A Tanuri; G Schochetman; M A Rayfield
Journal:  Emerg Infect Dis       Date:  1995 Jul-Sep       Impact factor: 6.883

6.  Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology.

Authors:  F Gao; L Yue; D L Robertson; S C Hill; H Hui; R J Biggar; A E Neequaye; T M Whelan; D D Ho; G M Shaw
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

7.  Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France.

Authors:  I Loussert-Ajaka; M L Chaix; B Korber; F Letourneur; E Gomas; E Allen; T D Ly; F Brun-Vézinet; F Simon; S Saragosti
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103
  7 in total
  14 in total

1.  Evaluation of United States-licensed human immunodeficiency virus immunoassays for detection of group M viral variants.

Authors:  W H Koch; P S Sullivan; C Roberts; K Francis; R Downing; T D Mastro; J Nkengasong; D Hu; S Masciotra; C Schable; R B Lal
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

2.  Blood screening by nucleic acid amplification technology: current issues, future challenges.

Authors:  J L Gallarda; E Dragon
Journal:  Mol Diagn       Date:  2000-03

3.  Performance of a multiplex qualitative PCR LCx assay for detection of human immunodeficiency virus type 1 (HIV-1) group M subtypes, group O, and HIV-2.

Authors:  K Abravaya; C Esping; R Hoenle; J Gorzowski; R Perry; P Kroeger; J Robinson; R Flanders
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02).

Authors:  Alessandra Amendola; Licia Bordi; Claudio Angeletti; Enrico Girardi; Giuseppe Ippolito; Maria R Capobianchi
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

5.  The molecular population genetics of HIV-1 group O.

Authors:  Philippe Lemey; Oliver G Pybus; Andrew Rambaut; Alexei J Drummond; David L Robertson; Pierre Roques; Michael Worobey; Anne-Mieke Vandamme
Journal:  Genetics       Date:  2004-07       Impact factor: 4.562

6.  Results of the Abbott RealTime HIV-1 assay for specimens yielding "target not detected" results by the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test.

Authors:  N Esther Babady; Jeffrey J Germer; Joseph D C Yao
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

7.  Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0.

Authors:  P Swanson; V Soriano; S G Devare; J Hackett
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 8.  Non-M variants of human immunodeficiency virus type 1.

Authors:  Thomas Mourez; François Simon; Jean-Christophe Plantier
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Efficiencies of four versions of the AMPLICOR HIV-1 MONITOR test for quantification of different subtypes of human immunodeficiency virus type 1.

Authors:  K Triques; J Coste; J L Perret; C Segarra; E Mpoudi; J Reynes; E Delaporte; A Butcher; K Dreyer; S Herman; J Spadoro; M Peeters
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.

Authors:  A S Vallari; R K Hickman; J R Hackett; C A Brennan; V A Varitek; S G Devare
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.